Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 19/8/2019
SIETES contiene 92796 citas

 
 
 1 a 20 de 34 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
van Eijk AM, Zulaika G, Lenchner M, Mason L, Sivakami M, Nyothach E, Unger H, Laserson KFPhillips-Howard PA. Menstrual cup use, leakage, acceptability, safety, and availability: a systematic review and meta-analysis. The Lancet Public Health 2019;4:1. [Ref.ID 103161]
2. Cita con resumen
Vaucher P, Druais P-L, Waldvogel S, Favrat B. Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: a randomized controlled trial. Can Med Assoc J 2012;184:1. [Ref.ID 92929]
5.Tiene citas relacionadas Cita con resumen
Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet 2006;368:804-13. [Ref.ID 77961]
6.
Grady-Weliky TA. Premenstrual dysphoric disorder. N Engl J Med 2003;348:433-8. [Ref.ID 64930]
7.
Rushton D H, Dover R, Wainsbury AW, Norris M J, Gilkes JJH, Ramsay I D. Iron deficiency is neglected in women's health. BMJ 2002;325:1176-7. [Ref.ID 64123]
8.
9. Cita con resumen
Tan KS. Premenstrual asthma: epidemiology, pathogenesis and treatment. Drugs 2001;61:2079-86. [Ref.ID 59695]
10.
Maestri E, D'Amico R, Magrini N. Approccio pratico ai disturbi premestruali. Informazioni sui Farmaci 2001;25:56-61. [Ref.ID 57860]
11. Cita con resumen
Anónimo. Fluoxetine (Sarafem®) for premenstrual disphoric disorder. Med Lett Drugs Ther 2001;43:5-6. [Ref.ID 56309]
12.
The Iowa Women's Health Study. Menstrual history and risk of hip fractures in postmenopausal women. The Iowa Women's Health Study. Am J Epidemiol 2001;153:251-5. [Ref.ID 55102]
13.
Anónimo. Rizatriptan for menstrual migraine in EC. Scrip 2000;2576:23. [Ref.ID 52842]
15.Tiene citas relacionadas
Bryant G, Scott I, Worrall A. Is norethisterone a lifestyle drug? Health is not merely the absence of disease. BMJ 2000;320:1605. [Ref.ID 51445]
16.
Zaigler M, Rietbrock S, Szymanski J, Dericks-Tan JSE, Staib AH, Fuhr U. Variation of CYP1A2-dependent caffeine metabolism during menstrual cycle in healthy women. Int J Clin Pharmacol Ther 2000;38:235-44. [Ref.ID 50696]
17. Cita con resumen
Thomas SL, Ellertson C. Nuisance or natural and healthy: should monthly menstruation be optional for women?. Lancet 2000;355:922-4. [Ref.ID 49888]
18.Tiene citas relacionadas Cita con resumen
Shakespeare J, Neve E, Hodder K. Is norethisterone a lifestyle drug? Results of database analysis. BMJ 2000;320:291. [Ref.ID 49081]
19.
Matsuki S, Kotegawa T, Tsutsumi K, Nakamura K, Nakano S. Pharmacokinetic changes of theophylline and amikacin through the menstrual cycle in healthy women. J Clin Pharmacol 1999;39:1256-62. [Ref.ID 48389]
20. Cita con resumen
Kamimori GH, Joubert A, Otterstetter R, Santaromana M, Eddington ND. The effect of the menstrual cycle on the pharmacokinetics of caffeine in normal, healthy eumenorrheic females. Eur J Clin Pharmacol 1999;55:445-9. [Ref.ID 46182]
Seleccionar todas
 
 1 a 20 de 34 siguiente >>